Aclidinium
آکلیدینیوم
🌬️ Respiratory SystemLong-acting muscarinic antagonist (LAMA)
Market / country: 🇺🇸 USA
Tudorza Pressair (US)
🧮 Dose calculator
Chronic obstructive pulmonary disease (COPD) · Regimen source: FDA Tudorza Pressair · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Severe hypersensitivity to milk proteins; hypersensitivity to aclidinium. FDA Tudorza Pressair · 4
Warnings
- • Not for acute episodes; paradoxical bronchospasm; worsening narrow-angle glaucoma and urinary retention; hypersensitivity. FDA Tudorza Pressair · 5
Formulations
- 400 mcg per actuation (Pressair) — inhaler 🇺🇸 USA FDA Tudorza Pressair · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Tudorza Pressair · 8.1
“Risk Summary There are no adequate and well controlled studies of TUDORZA PRESSAIR in pregnant women to inform drug associated risks.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Tudorza Pressair · 8.2
“Risk Summary There are no available data on the effects of TUDORZA PRESSAIR or aclidinium bromide on the breastfed child or on milk production or presence in human milk.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Tudorza Pressair · 8.4
“The safety and effectiveness of TUDORZA PRESSAIR in pediatric patients have not been established.”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Tudorza Pressair · 8.5
“No overall differences in safety or effectiveness were observed between these subjects and younger subjects.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA202450
- DailyMed (FDA label)FDA Tudorza Pressair
- MedlinePlus (NIH)Aclidinium Oral Inhalation
- WHO ATC/DDDR03BB05
- Darooyab (Iran)❌ None
🇮🇷 Not found in Iran list Darooyab · search
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Tudorza Pressair · 3FDA Tudorza Pressair · 2FDA Tudorza Pressair · 4FDA Tudorza Pressair · 5FDA Tudorza Pressair · SPL approval / marketing categoryFDA Tudorza Pressair · 8.1FDA Tudorza Pressair · 8.2FDA Tudorza Pressair · 8.4FDA Tudorza Pressair · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · search
- Clinical review⚠ Unverified